Zobrazeno 1 - 10
of 92
pro vyhledávání: '"Daniel E. Roos"'
Publikováno v:
Journal of Medical Radiation Sciences, Vol 66, Iss 1, Pp 66-69 (2019)
Abstract We describe the use of radiotherapy for parotid IgG4‐related disease (IgG4‐RD), initially misdiagnosed as Kimura's disease, with sustained good partial response in a 37‐year‐old male. To the best of our knowledge, this is the first r
Externí odkaz:
https://doaj.org/article/7522eafe667845c0b65eb530f674e4fc
Autor:
Minjae Lah, Amy Shorthouse, Melissa L James, Ramkumar Govindaraj, Kathy Pope, Daniel E. Roos, Tanya Holt
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 111:959-964
Purpose First developed in Canada in the 1990s, Rapid Access Palliative Radiation Therapy (RAPRT) clinics have subsequently spread internationally to expedite treatment for near end-of-life patients, sparing them the need for multiple visits to the d
Publikováno v:
Journal of Medical Imaging and Radiation Oncology. 66:117-128
Introduction A recent survey found that Rapid Access Palliative Radiation Therapy (RAPRT) clinics have not been widely embraced in Australia and New Zealand for many reasons. The purpose of this narrative is to describe the transition of a Brisbane,
Publikováno v:
Australian Journal of General Practice. 49:496-499
Background: Skin cancer is the most common malignancy that is managed in general practice, and non-melanoma skin cancer (NMSC) comprises the vast majority of presentations. Radiation therapy (RT) plays an important part in the management of NMSC and
Autor:
Richard W. Tsang, Andrew Macann, Peter C. O'Brien, David J. Joseph, John F. Seymour, Richard Fisher, Jayasingham Jayamohan, Michael MacManus, S. Davis, Daniel E. Roos, David R. H. Christie, Bev McClure
Publikováno v:
Journal of Clinical Oncology. 36:2918-2925
Purpose Follicular lymphoma (FL) is curable by involved-field radiotherapy (IFRT) in < 50% of patients with stage I to II disease. We hypothesized that adding systemic therapy to IFRT would improve long-term progression-free survival (PFS). Patients
Publikováno v:
Journal of Medical Radiation Sciences, Vol 66, Iss 1, Pp 66-69 (2019)
Journal of Medical Radiation Sciences
Journal of Medical Radiation Sciences
We describe the use of radiotherapy for parotid IgG4‐related disease (IgG4‐RD), initially misdiagnosed as Kimura's disease, with sustained good partial response in a 37‐year‐old male. To the best of our knowledge, this is the first reported c
Autor:
Richard W. Tsang, C. Anne, Daniel E. Roos, Andrew Wirth, Mathias Bressel, Michael MacManus, Peter O’Brien, John F. Seymour, Stephen Lade
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 111:S105
Purpose/Objective(s) This phase 2 multicenter clinical trial evaluated the effectiveness and safety of radiotherapy in localized non-gastric marginal zone lymphoma (MZL) and assessed the prevalence of markers of autoimmunity and Helicobacter pylori (
Publikováno v:
Journal of Medical Imaging and Radiation Oncology. 61:418-423
Introduction The Royal Australian and New Zealand College of Radiologists (RANZCR) and other medical colleges have provided research grants from their budgets for many years. This survey-based project aimed to determine whether the RANZCR Faculty of
Autor:
Daniel E. Roos
Publikováno v:
Practical Radiation Oncology. 9:382-383
Autor:
John Gibson, Andrew Wirth, Bereha Khodr, S. Davis, Diana Zannino, H. Miles Prince, Mark P. Hertzberg, Janey M. Stone, Daniel E. Roos, Peter O’Brien
Publikováno v:
International journal of radiation oncology, biology, physics. 103(5)
Purpose The role of involved-field radiation therapy (IFRT) with autologous stem cell transplantation (ASCT) for lymphomas remains uncertain. Methods and Materials In this prospective, multicenter study, patients undergoing ASCT for relapsed/refracto